Comment on: Occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian hospitals [1]

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 4, 2007, Pages 799-800

  Walsh, T R ^a   Toleman, M A ^a   Jones, R N ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b JMI LABORATORIES   (United States)

Author keywords

ESBLs; Escherichia coli; India; Klebsiella spp

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE;

AMPLICON; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATION; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE INSERTION; GENE POOL; GENOTYPE; INDIA; KLEBSIELLA; LETTER; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS; ANTIBIOTIC RESISTANCE; DRUG EFFECT; ENTEROBACTER INFECTION; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; NOTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; HUMANS; INDIA; KLEBSIELLA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34250024681     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl532     Document Type: Letter

References (6)

1. Ensor VIM, Shahid M, Evans JT et al. Occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 2006; 58: 1260-3.
2. The India Antimicrobial Resistance Study Group, Mathai D, Rhomberg PR et al. Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against recent clinical isolates from India: A survey of ten medical center laboratories. Diagn Microbiol Infect Dis 2002; 44: 367-77.
3. Jones RN, Rhomberg PR, Vamam DJ et al. A comparison of the antimicrobial activity of meropenem and selected broad-spectrum antimicrobials tested against multi-drug resistant Gram-negative bacilli including bacteraemic Salmonella spp.: Initial studies for the MYSTIC programme in India. Int J Antimicrob Agents 2002; 20: 426-31.
4. Toleman MA, Beidenbach D, Jones RN et al. Molecular characterisation of β-lactamases from Escherichia coli isolated from a multicentre trial in India: Benchmark report from the MYSTIC program. In: Abstracts of the Forty-second Intersdence Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 2002. Abstract C2-1872, p. 114, American Society for Microbiology, Washington, DC, USA.
5. Karim A, Poirel L, Nagarajan S et al. Plasmid-mediated extended-spectrum β-lactamase (CTX-M3-Iike) from India and association with insertion sequence IS Ec1p. FEMS Microbiol Lett 2001; 201 237-41.
6. CTX-M genes. FEMS Microbiol Lett 2004; 234: 201-7.